Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHanifi Bal

About this trial

Multiple sclerosis (MS) is a chronic neurological disease associated with reduced muscle strength, impaired mobility, increased fatigue, and deterioration in muscle morphology. Rectus femoris muscle atrophy and reduced muscle quality have been linked to functional limitations and decreased mobility in individuals with MS.

Blood flow restriction (BFR) training is a rehabilitation strategy that combines low-load exercise with partial vascular occlusion, enabling muscular adaptations comparable to those achieved with higher exercise loads. Although BFR has demonstrated promising results in several clinical populations, evidence regarding its effects on muscle morphology in individuals with relapsing-remitting multiple sclerosis (RRMS) remains limited.

The purpose of this randomized controlled trial is to investigate the effects of low-load BFR exercise on rectus femoris muscle morphology in individuals with RRMS. Thirty participants with RRMS (EDSS 2.5-3.5) will be randomly assigned to one of three groups: a BFR exercise group, a sham-BFR exercise group, or an exercise-only control group. All participants will complete the same supervised exercise program twice weekly for eight weeks.

The primary outcome will be rectus femoris muscle thickness assessed by ultrasonography. Secondary outcomes will include rectus femoris echo intensity, knee extensor muscle strength, Timed 25-Foot Walk performance, Nine-Hole Peg Test performance, Symbol Digit Modalities Test scores, and Modified Fatigue Impact Scale scores.

This study aims to determine whether the addition of blood flow restriction to a standardized low-load exercise program results in superior morphological and functional adaptations compared with sham-BFR and exercise-only conditions in individuals with RRMS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of relapsing-remitting multiple sclerosis according to revised McDonald criteria

EDSS score between 2.5 and 3.5

Clinically stable disease

No relapse within the previous 3 months

Disqualifiers

Peripheral vascular disease

Uncontrolled hypertension

Severe cardiovascular disease

Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Blood Flow Restriction Training

    Device

    Low-load exercise performed with individualized blood flow restriction applied to both proximal thighs using pneumatic cuffs inflated to 50-60% of arterial occlusion pressure.

  • Sham Blood Flow Restriction

    Device

    Low-load exercise performed with pneumatic cuffs applied to both proximal thighs but inflated to a pressure insufficient to produce meaningful vascular occlusion.

  • Low-Load Exercise Program

    Behavioral

    Participants will perform a supervised low-load exercise program twice weekly for 8 weeks. The exercise program will include warm-up activities, quadriceps-focused strengthening exercises, cycling exercise, and cool-down activities. The same exercise program will be applied to all study groups.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: BFR Exercise GroupExperimental treatment 2 interventions
Group B: Sham BFR GroupSham comparator 2 interventions
Group C: Exercise Control GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Rectus Femoris Muscle Thickness

Rectus femoris muscle thickness will be assessed using B-mode ultrasonography. Measurements will be obtained at baseline and after the 8-week intervention period. The primary outcome will be the change in rectus femoris muscle thickness from baseline to post-intervention.

Time frame
Baseline and Week 8

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hanifi Bal

Lead sponsor

Istinye University

Sponsor institution

Dicle University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: